Special Issue Title:

Hyperthermic Intraperitoneal Chemotherapy to Gynaecological Oncology

Deadline for manuscript submissions: 30 June 2021

Print Special Issue Flyer (2)

Special Issue Editor

  • Guest Editor

    Anastasia Prodromidou, MDE-MailWebsite

    Clinic of Gynecological Oncology, Metaxa Memorial Cancer Hospital, Piraeus, Greece

    Interests: Gynaecology; Obstetrics; Pediatrics

  • Guest Editor

    Alexandros Fotiou, MDE-MailWebsite

    Gynaecological Oncology Department - Metaxa Cancer Hospital, Piraeus, Greece

    Interests: Gynaecological oncology; Robotic and laparoscopic surgery ; Endometrial cancer

  • Guest Editor

    Christos Iavazzo, MDE-MailWebsite

    Gynaecological Oncology Department - Metaxa Cancer Hospital, Piraeus, Greece

    Interests: robotics; laparoscopic surgery oncology

  • Guest Editor

    Victoria Psomiadou, MDE-MailWebsite

    Gynaecological Oncology Department - Metaxa Cancer Hospital, Piraeus, Greece

    Interests: Gynaecological oncology; Robotic and laparoscopic surgery; Ovarian cancer

Special Issue Information

Dear Colleagues,

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) as a standard treatment procedure in the field of gynecologic oncology is controversial. Although widely discussed and studied as a subsidiary method of interval cytoreductive surgery, HIPEC remains debatable even in the management of advanced and recurrent epithelial ovarian cancer. Hence, many large trials support the safety and efficacy of the method regarding the extension of overall survival in well selected EOC patients. Interestingly, encouraging findings support the effectiveness of HIPEC even performed at the time of primary debulking surgery in stage III EOC patients, by whom a complete cytoreduction is anticipated, and large ongoing trials’ results will be shortly available. The promising results of studies investigating HIPEC combined with adjuvant chemotherapy with platinum compounds in the management of advanced stage peritoneal disseminated endometrial and cervical cancer add to recent evidence and verify further more thorough research. Remarkably, peritoneal carcinomatosis from non-gynecological origin in patients with abdominally confined disease has been considered an indication for hyperthermic intraperitoneal chemotherapy. Originally in cases of pseudomyxoma peritonei and malignant peritoneal mesothelioma followed by gastric, colorectal and even breast cancer patients with pelvic peritoneal metastases, many authors have published supporting data about explorative surgery followed by cytoreduction and HIPEC.

Nevertheless, more prospective multi-center randomized studies need to be designed in order to draw safe conclusions and determine which patients could benefit from the implementation of this approach. Further issues to be determined encompass robust data of the surgical procedures, the art and dose of chemotherapeutic regimens as well as the temperature and duration of the hyperthermic arm that will warrant the optimal oncological outcome and support the recommendation of HIPEC by the gynecological cancer community.

The aim of our special issue is to publish interesting studies in the field exploring the indications, technique, future challenges. We welcome authors to submit case reports, case series, retrospective studies, randomized trials and reviews regarding the role of HIPEC in different gynecological cancers.

Prof. Dr. Christos Iavazzo, Dr. Alexandros Fotiou, Alexandros Fotiou, and Dr. Anastasia Prodromidou

Guest Editors

Keywords

Gynecologic cancer;Hysteroscopy;Cancer prevention;Early diagnosis;Cancer screening;Pre-operative cancer workup

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (5 papers)

Open Access Special Issue

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in treatment of advanced ovarian cancer. A review of the literature

Victoria Psomiadou,Alexandros Fotiou,Anastasia Prodromidou,Christos Iavazzo

DOI: 10.31083/j.ejgo4301004

(This article belongs to the Special Issue Hyperthermic Intraperitoneal Chemotherapy to Gynaecological Oncology)

Abstract ( 381 ) PDF (468.49 kB) ( 151 )

Open Access Special Issue

Is minimal invasive surgical treatment of ovarian cancer plus HIPEC a utopia? A review of the literature

Victoria Psomiadou,Alexandros Fotiou,Anastasia Prodromidou,Christos Iavazzo

DOI: 10.31083/j.ejgo4205149

(This article belongs to the Special Issue Hyperthermic Intraperitoneal Chemotherapy to Gynaecological Oncology)

Abstract ( 315 ) PDF (151.16 kB) ( 107 )

Open Access Special Issue

Perioperative outcomes in patients treated with total parietal peritonectomy and multi-visceral resections with or without HIPEC at different time points in the history of advanced ovarian cancer

Aditi Bhatt,Praveen Kammar,Snita Sinukumar,Gaurav Goswami,Bikas Mishra,Mrugank Bhavsar,Sakina Shaikh,Sameer Bhosale,Deepesh Aggarwal,Nitin Bhorkar,Sanket Mehta

DOI: 10.31083/j.ejgo4204108

(This article belongs to the Special Issue Hyperthermic Intraperitoneal Chemotherapy to Gynaecological Oncology)

Abstract ( 329 ) PDF (137.79 kB) ( 139 )

Open Access Special Issue

CRS and HIPEC in a patient with recurrent ovarian cancer after PDS and adjuvant chemotherapy, a case report and MDT discussion

Alexandros Fotiou,Victoria Psomiadou,Anastasia Prodromidou,Christos Iavazzo

DOI: 10.31083/j.ejgo4302043

(This article belongs to the Special Issue Hyperthermic Intraperitoneal Chemotherapy to Gynaecological Oncology)

Abstract ( 400 ) PDF (211.55 kB) ( 143 )

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences